Community pharmacy care model could free up 18 million GP appointments

Community pharmacy care model could free up 18 million GP appointments

July 4 2018 A new model of care with community pharmacists providing a day’s support each...

New CAVGP website launches highlighting general practice jobs around Cardiff

New CAVGP website launches highlighting general practice jobs around Cardiff

June 29 2018 A new jobs website highlighting health professionals and clerical staff roles in...

£10,000 ‘golden hellos’ announced to entice nursing post-grads into ‘difficult-to-recruit’ sectors

£10,000 ‘golden hellos’ announced to entice nursing post-grads into ‘difficult-to-recruit’ sectors

May 15 2018 Funding of £10 million will be available to increase recruitment of nurses into...

Scotland announces £6.9m investment in primary care staff training targeted at nursing

Scotland announces £6.9m investment in primary care staff training targeted at nursing

May 9 2018 Funding of £6.9 million will be invested in training primary healthcare staff,...

  • Community pharmacy care model could free up 18 million GP appointments

    Community pharmacy care model could free up 18 million GP appointments

    Wednesday, 04 July 2018 15:18
  • New CAVGP website launches highlighting general practice jobs around Cardiff

    New CAVGP website launches highlighting general practice jobs around Cardiff

    Friday, 29 June 2018 15:25
  • £10,000 ‘golden hellos’ announced to entice nursing post-grads into ‘difficult-to-recruit’ sectors

    £10,000 ‘golden hellos’ announced to entice nursing post-grads into ‘difficult-to-recruit’ sectors

    Tuesday, 15 May 2018 12:13
  • Scotland announces £6.9m investment in primary care staff training targeted at nursing

    Scotland announces £6.9m investment in primary care staff training targeted at nursing

    Wednesday, 09 May 2018 16:15

a doctor in consultation imageFebruary 9 2018

Precautions around the use of dopaminergic drugs in Parkinson’s disease are included in a new NICE Quality Standard. 


One of the five quality statements in QS 164 says that patients receiving dopaminergic therapy should be given advice about the risk of developing impulse control disorders. The quality statement has been included as “dopaminergic therapy, especially with dopamine agonists, is associated with a risk of developing impulse control disorders,” says NICE.

“It is important to discuss this risk and provide information to adults with Parkinson's disease, and their family members and carers, when starting treatment and at least annually. This will help them to recognise the symptoms and know where to get help if these develop.”

NICE expects healthcare professionals to “provide oral and written information about the risk of developing impulse control disorders to adults with Parkinson's disease when starting dopaminergic therapy (not just dopamine agonists) and discuss this with them at least annually.” They should also provide information for family members and carers if appropriate.

In addition, “oral and written information should be given about:

  • the different types of impulse control disorders (for example, compulsive gambling, hypersexuality, binge eating and obsessive shopping);
  • the increased risk of impulse control disorders developing with dopamine agonists;
  • the risk that impulse control disorders may be concealed by the person affected;
  • who to contact if impulse control disorders develop;
  • the possibility that if problematic impulse control disorders develop, dopamine agonist therapy will be reviewed and may be reduced or stopped.”

A sperate quality statement says that patients should have a point of contact with specialist services. They should also be “referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.”

This means GPs and others need to be “aware of local referral pathways to physiotherapy, occupational therapy and speech and language therapy for adults with Parkinson’s disease.” Healthcare professionals should “carry out regular assessments of balance, motor function, activities of daily living, communication, swallowing and saliva for adults with Parkinson’s disease and refer them for physiotherapy, occupational therapy or speech and language therapy specific for Parkinson’s disease if problems are identified.”

A further quality statement says patients should have access to clozapine and patient monitoring for treating hallucinations and delusions.

The Quality Standards should be used alongside NICE guideline NG71 on Parkinson’s disease in adults.

Links:
NICE QS 164 Parkinson’s Disease           
NICE Guideline on Parkinson’s disease in adults NG71   

Management News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...